What are the practical implications for treating diabetes in light of recent evidence? Updated recommendations from the Global Partnership for Effective Diabetes Management
- PMID: 20368223
- DOI: 10.1177/1479164109341691
What are the practical implications for treating diabetes in light of recent evidence? Updated recommendations from the Global Partnership for Effective Diabetes Management
Abstract
The Global Partnership for Effective Diabetes Management was established in 2004 to provide practical guidance to improving glycaemic control for people with type 2 diabetes. Those recommendations have been updated to take account of recent trials assessing the effects of intensive glucose control. We continue to emphasis the importance of early and sustained glycaemic control, aiming for HbA( 1c) 6.5-7% wherever safe and appropriate. Individualisation of targets and the management process is strongly encouraged to accommodate patient circumstances and to avoid hypoglycaemia. Prompt introduction of combinations of agents is suggested when monotherapy is inadequate.Treatments will preferably address the underlying pathophysiology of type 2 diabetes and integrate within a wider programme of care which also aims to reduce modifiable cardiovascular risk factors and better equip patients in the self-management of their condition.
Similar articles
-
Individualized glycaemic targets and pharmacotherapy in type 2 diabetes.Diab Vasc Dis Res. 2013 Sep;10(5):397-409. doi: 10.1177/1479164113490765. Epub 2013 May 27. Diab Vasc Dis Res. 2013. PMID: 23711582 Review.
-
Optimal glycaemic control in elderly people with type 2 diabetes: what does the evidence say?Drug Saf. 2015 Jan;38(1):17-32. doi: 10.1007/s40264-014-0247-7. Drug Saf. 2015. PMID: 25481812 Review.
-
Tailoring treatment to the individual in type 2 diabetes practical guidance from the Global Partnership for Effective Diabetes Management.Int J Clin Pract. 2010 Feb;64(3):295-304. doi: 10.1111/j.1742-1241.2009.02227.x. Int J Clin Pract. 2010. PMID: 20456169 Free PMC article. Review.
-
The 2018 update of the American College of Physicians glycaemic management recommendations: An invitation to continued inertia?Diabetes Obes Metab. 2018 Aug;20(8):1809-1811. doi: 10.1111/dom.13325. Epub 2018 May 10. Diabetes Obes Metab. 2018. PMID: 29658190
-
Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials.Ann Intern Med. 2011 Apr 19;154(8):554-9. doi: 10.7326/0003-4819-154-8-201104190-00007. Ann Intern Med. 2011. PMID: 21502652 Review.
Cited by
-
New therapeutic algorithm of Type 2 diabetes: lights and shadows.J Endocrinol Invest. 2011 Jan;34(1):65-8. doi: 10.1007/BF03346697. Epub 2011 Feb 4. J Endocrinol Invest. 2011. PMID: 21297380 No abstract available.
-
Insulin degludec/insulin aspart combination for the treatment of type 1 and type 2 diabetes.Vasc Health Risk Manag. 2014 Aug 5;10:465-75. doi: 10.2147/VHRM.S40097. eCollection 2014. Vasc Health Risk Manag. 2014. PMID: 25143741 Free PMC article. Review.
-
Achieving glycaemic control without weight gain, hypoglycaemia, or gastrointestinal adverse events in type 2 diabetes in the SUSTAIN clinical trial programme.Diabetes Obes Metab. 2018 Oct;20(10):2426-2434. doi: 10.1111/dom.13396. Epub 2018 Jul 9. Diabetes Obes Metab. 2018. PMID: 29862621 Free PMC article.
-
Effect of Semaglutide on the Pharmacokinetics of Metformin, Warfarin, Atorvastatin and Digoxin in Healthy Subjects.Clin Pharmacokinet. 2017 Nov;56(11):1391-1401. doi: 10.1007/s40262-017-0532-6. Clin Pharmacokinet. 2017. PMID: 28349387 Free PMC article. Clinical Trial.
-
Effect of once-weekly semaglutide versus thrice-daily insulin aspart, both as add-on to metformin and optimized insulin glargine treatment in participants with type 2 diabetes (SUSTAIN 11): A randomized, open-label, multinational, phase 3b trial.Diabetes Obes Metab. 2022 Sep;24(9):1788-1799. doi: 10.1111/dom.14765. Epub 2022 Jun 29. Diabetes Obes Metab. 2022. PMID: 35546450 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous